Literature DB >> 7520700

The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.

H W Schroeder1, G Dighiero.   

Abstract

CD5+ B cells predominate early in ontogeny and have been associated with autoantibody production. In chronic lymphocytic leukemia (CLL), B lymphocytes express CD5 and frequently produce autoantibodies using developmentally regulated variable (V)-gene segments. Does the self-reactivity observed in CLL reflect transformation of a 'fetal' lineage of cells, or could overexpansion of these B cells occur as a consequence of antigen stimulation? Harry Schroeder and Guillermo Dighiero have reviewed the literature describing antibody sequences in CLL and have compared them with the 'fetal' repertoire. This analysis indicates that CLL cells use a repertoire characteristic of mature cells, and suggests that antigen may play a role in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520700     DOI: 10.1016/0167-5699(94)90009-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  62 in total

1.  HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia.

Authors:  S M Moazzeni; A A Amirzargar; F Shokri
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Clonal evolution of B cells in transformation from low- to high-grade lymphoma.

Authors:  A Matolcsy; E J Schattner; D M Knowles; P Casali
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 4.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

5.  Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.

Authors:  Davorka Messmer; Gloria Telusma; Tarun Wasil; Bradley T Messmer; Steven Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

6.  Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.

Authors:  George F Widhopf; Craig J Goldberg; Traci L Toy; Laura Z Rassenti; William G Wierda; John C Byrd; Michael J Keating; John G Gribben; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2007-08-03       Impact factor: 22.113

7.  Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.

Authors:  Roberto Marasca; Rossana Maffei; Monica Morselli; Patrizia Zucchini; Ilaria Castelli; Silvia Martinelli; Marcella Fontana; Sara Ravanetti; Monica Curotti; Giovanna Leonardi; Katia Cagossi; Giovanni Partesotti; Giuseppe Torelli
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

Review 8.  Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.

Authors:  Gerard Tobin; Richard Rosenquist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

9.  Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Authors:  Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

Review 10.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.